All
Outcomes
Market
Price
AI Fair
Value
Value
Edge
Micron
YesNo
Boeing
YesNo
Anduril
YesNo
Nvidia
YesNo
Lockheed Martin
YesNo
Freeport-McMoRan
YesNo
Samsung Electronics
YesNo
TikTok US / Bytedance
YesNo
OpenAI
YesNo
Eli Lilly
YesNo
GlobalFoundries
YesNo
Pfizer
YesNo
Anthropic
YesNo
D-Wave
YesNo
Palantir
YesNo
Rigetti
YesNo
TSMC
YesNo
IonQ
YesNo
AI Insights:
03.06 15:26 UpdatedFair Value Reasoning:
Pricing is driven by Trump & Lutnick's 'Sovereign Wealth Fund (SWF)' and 'Equity for Orders/Subsidies' rhetoric. 1. TikTok: remains the highest probability target given explicit mentions of SWF acquisition, though fervor has cooled slightly. 2. Boeing/Micron/GlobalFoundries: As recipients of CHIPS Act funding or distressed strategic assets, these fit Lutnick's logic that 'taxpayers deserve a return (equity)' perfectly. 3. IonQ/D-Wave/Rigetti: The quantum sector is seeing a speculative rally based on 'strategic tech' narratives, but lacks concrete news of government stakes; current prices likely exceed fair value (overreaction). 4. Anduril/Palantir: While defense darlings, they are winning contracts, not necessarily needing bailouts/equity injections; prices are sentiment-driven. 5. Pfizer/Eli Lilly: Despite 'warrants for vaccines' rhetoric, execution faces massive legal/political hurdles, making current prices overvalued.
Sign up to view more information
Rule Risk
There is moderate ambiguity regarding 'convertible rights'. CHIPS Act funding awards often include warrants (rights to buy stock) for the US government. If these warrants qualify as a 'stake' under the rules, companies like Micron or GlobalFoundries could resolve to 'Yes' simply by finalizing a subsidy agreement, without undergoing traditional nationalization or direct equity purchase. Distinction between non-binding prelim terms and binding agreements is also critical.
Exotics
This market sits on the edge between 'routine industrial policy' and 'extreme nationalization'. While the US government typically avoids direct equity stakes (except in crises like 2008), the rise of 'Sovereign AI' and the CHIPS Act moves the concept of state ownership in strategic assets from 'unthinkable' to a 'plausible policy debate'.
Hedging
TSM
MU
BA
NVDA
This market primarily hedges against 'Bailout' or 'Strategic Nationalization' risks. If the US government takes a stake in Boeing (BA), it likely implies severe distress requiring dilution (bearish for equity). For TSMC or Nvidia, a government stake would signal a structural shift in geopolitics or national security policy, creating a massive shock to tech valuations.
Movers
March 5, 2026 - March 6, 2026, prices for Quantum Computing (IonQ, Rigetti, D-Wave) and Defense Tech (Anduril, Palantir) surged collectively. For example, Anduril jumped from 26.5c to 52c, D-Wave from 12c to 51c, and Palantir from 17c to 49c. This was driven by a sudden spike in expectations that the Trump administration will execute strategic equity investments via the SWF, specifically targeting tech and defense supply chains, triggering FOMO buying.
February 9, 2026 - February 10, 2026, Micron's price surged from 8c to 37.5c following a stock rally and renewed rumors of a government stake after the Intel precedent.
February 3, 2026 - February 5, 2026, Pfizer and Eli Lilly prices rose to ~48c after Trump mentioned demanding 'warrants' for vaccine purchases during his SWF executive order signing.
Divergence
Significant divergence exists. The market is currently pricing in a scenario where the government takes stakes in almost *every* major tech/defense player (multiple options hovering near 50c), implying broad-brush nationalization or equity acquisition. However, mainstream financial analysis and historical precedent suggest the US government typically only takes equity in cases of extreme distress (e.g., Intel/Boeing) or forced divestiture (e.g., TikTok). The current pricing implies an extreme shift to 'state capitalism' that far exceeds stated policy (which targets specific strategic assets), indicating significant over-speculation.
